PINC 2015 – New Research to Focus on Tocotrienols and Renal Disease

pinc-2015-logo

Palm International Nutra-Cosmeceutical Conference (PINC 2015)

International conference to focus attention on palm oil’s health benefits

Palm phytonutrients in the form of vitamin E tocotrienols,carotenoids and phenolics are emerging as exciting micronutrients for human health, backed by rapidly emerging scientific outputs. PINC 2015, starting 2 August 2015 aims to highlight these positive benefits from the palm oil industry. New Research to focus on tocotrienols and renal disease.

Read More

In End-Stage Renal Disease Patients, Will Tocotrienols From Palm Oil Impact Restless Legs Syndrome?

End-stage renal disease (ERSD) is the last stage of chronic kidney disease where the kidneys function at under 10% to 15% of their normal capacity. At this stage, kidneys cannot effectively remove waste or excess fluid from the blood system, and dialysis or a kidney transplant is necessary to live.

A team of researchers led by Pramod Khosla, PhD, associate professor of nutrition and food science in the College of Liberal Arts and Sciences at Wayne State University, will study the effects of a daily supplement of a Tocotrienol-rich fraction from palm oil to see if it improves dyslipidemia, a disorder of lipoprotein metabolism that may be manifested by a decrease in the “good” high-density lipoprotein (HDL) cholesterol in patients with ESRD who are on hemodialysis. Tocotrienols are a form of Vitamin E and have been shown in recent years to have diverse health effects. In addition, Khosla’s team will explore the impact on symptoms such as inflammation and symptoms related to restless legs syndrome in the same cohort of patients.

Read More

Wayne State researching effects of tocotrienols from palm oil in end-stage renal disease patients

DETROIT – End-stage renal disease (ERSD) is the last stage of chronic kidney disease where the kidneys function at under 10 to 15 percent of their normal capacity. At this stage, kidneys cannot effectively remove waste or excess fluid from the blood system, and dialysis or a kidney transplant is necessary to live.

A team of researchers led by Pramod Khosla, Ph.D., associate professor of nutrition and food science in the College of Liberal Arts and Sciences at Wayne State University, will study the effects of a daily supplement of a Tocotrienol-rich fraction from palm oil to see if it improves dyslipidemia, a disorder of lipoprotein metabolism that may be manifested by a decrease in the “good” high-density lipoprotein (HDL) cholesterol in patients with ESRD who are on hemodialysis. Tocotrienols are a form of Vitamin E and have been shown in recent years to have diverse health effects. In addition, Khosla’s team will explore the impact on symptoms such as inflammation and symptoms related to Restless Leg Syndrome in the same cohort of patients.

Read More

Page 1 of 11